Recombinant Human MCP-4 (CCL13)
Catalog No : IGX-RP641
295.27€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant Human MCP-4 (CCL13) | ||
|---|---|---|---|
| Catalog No | IGX-RP641 | ||
| Supplier’s Catalog No | IGX-RP641 | ||
| Supplier | ImuGeX | ||
| Source antigen | E. coli | ||
| Reactivity | Human | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 9 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | Monocyte chemotactic protein 4, CCL13, NCC-1, C-C motif chemokine 13, Small-inducible cytokine A13, MCP4, NCC1, SCYA13<br/>Recombinant Human Monocyte Chemoattractant Protein-4 (CCL13) | ||
| Grade | Highly Purified | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Form | Lyophilized from a 0.2 μm filtered solution in PB, 100mM NaCl, pH 7.5 | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Description | Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) is member of a distinct, structurally-related subclass of CC chemokines. MCP-4/CCL13 is a major chemoattractants for eosinophils, basophils, monocytes, and T lymphocytes. The MCP protein family bind to specific G-protein-coupled receptors, initiating a signal cascade within the cell. Expression of MCP-4/CCL13 mRNA and protein is greater in the sputum, epithelium, submucosal inflammatory cells, and bronchoalveolar lavage fluid of asthmatics than in healthy individuals. Involvement of MCPs has also been demonstrated in renal inflammation and atopic dermatitis. The expression of this protein is also correlated with enhanced inflammatory immune responses during immunotherapy. The recombinant construct corresponds to the “short-chain†of CCL13 spanning amino acids 24 – 98. | ||
Product Details
© 2020 Imugex All Rights Reserved